MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 21.03.2026
ProQR Therapeutics N.V. EV 2011-2026 | PRQR
EV Jährlich ProQR Therapeutics N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -29 M | -70 M | -22.4 M | 9.86 M | -22.5 M | 154 M | 203 M | 366 M | 50.7 M | 50.1 M | 38.5 M | 228 M | 4.59 M | 239 K | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 366 M | -70 M | 68.6 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K |  USA |
 |
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | USA |
 |
Amgen
AMGN
|
189 B | $ 345.02 | 1.52 % | $ 186 B | USA |
 |
AlloVir
ALVR
|
-55.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
4.03 B | $ 12.59 | 2.19 % | $ 3.95 B | USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Applied Therapeutics
APLT
|
563 M | - | - | $ 8.42 M | USA |
 |
argenx SE
ARGX
|
-2.13 B | $ 777.72 | 1.61 % | $ 25 B |  Niderland |
 |
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
168 B | - | 2.54 % | $ 160 B |  France |
 |
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 23.65 | 1.63 % | $ 3.01 B | USA |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | France |
 |
Autolus Therapeutics plc
AUTL
|
629 M | $ 1.43 | 4.78 % | $ 381 M |  Britain |
 |
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
59.6 B | - | - | $ 96.9 B | Britain |
 |
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-720 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.86 | 2.74 % | $ 9.29 B |  Australia |
 |
BioNTech SE
BNTX
|
-4.91 B | $ 91.14 | 1.7 % | $ 27.2 B | Germany |
 |
CymaBay Therapeutics
CBAY
|
3.36 B | - | - | $ 3.45 B | USA |
 |
Advaxis
ADXS
|
-3.02 M | - | -9.65 % | $ 45.9 M | USA |
 |
Aytu BioScience
AYTU
|
-15.2 M | $ 2.66 | 3.5 % | $ 16.7 M | USA |
 |
Burford Capital Limited
BUR
|
3.22 B | $ 4.73 | 4.07 % | $ 775 M | Britain |
 |
Avid Bioservices
CDMO
|
661 M | - | - | $ 789 M | USA |
 |
Cidara Therapeutics
CDTX
|
9.99 M | - | - | $ 1.41 B | USA |
 |
Cabaletta Bio
CABA
|
253 M | $ 3.1 | 0.97 % | $ 311 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Checkpoint Therapeutics
CKPT
|
174 M | - | - | $ 169 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 3.03 | - | $ 6.59 B | Israel |
 |
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M |  Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
11.4 M | - | - | $ 231 M | USA |
 |
AgeX Therapeutics
AGE
|
3.93 M | - | -10.17 % | $ 12.2 K | USA |
 |
Cerus Corporation
CERS
|
632 M | $ 1.95 | 5.99 % | $ 372 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
14.7 M | - | - | $ 401 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | USA |
 |
Cellectar Biosciences
CLRB
|
-651 K | $ 2.8 | 1.82 % | $ 7.3 M | USA |
 |
CTI BioPharma Corp.
CTIC
|
664 M | - | - | $ 1.2 B | USA |
 |
AIkido Pharma
AIKI
|
9.53 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
36.2 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-2.16 M | - | -4.36 % | $ 27 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
1.24 B | - | - | $ 2.18 B | USA |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
2.02 B | - | - | $ 2.02 B | USA |
 |
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | Germany |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
119 M | $ 9.61 | -1.06 % | $ 128 M | USA |